R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: The influence of prior exposure to rituximab on outcome. A GEL/TAMO study

1. Martín, A.
2. Conde, E.
3. Arnan, M.
4. Canales, M.A.
5. Deben, G.
6. Sancho, J.M.
7. Andreu, R.
8. Salar, A.
9. García-Sanchez, P.
10. Vázquez, L.
11. Nistal, S.
12. Requena, M.-J.
13. Donato, E.M.
14. González, J.A.
15. León, Á.
16. Ruiz, C.
17. Grande, C.
18. González-Barca, E.
19. Caballero, M.-D.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3324/HAEMATOL.13440 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus